AERAS and IDRI Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine

May 9th, 2012|Press Releases|

Rockville, MD | Seattle, WA | May 9, 2012 Aeras and the Infectious Disease Research Institute (IDRI) announce today a new agreement to conduct joint development activities with respect to IDRI’s novel tuberculosis vaccine candidate. This collaboration reflects the [...]